Global Myelodysplastic Syndrome Market Is Estimated To Witness High Growth Owing To Increasing Awareness and Advances in Treatment Options
The global Myelodysplastic Syndrome Market is estimated to be valued at US$ 3,265.6 million in 2022 and is expected to exhibit a CAGR of 9.3% over the forecast period, from 2022 to 2030, as highlighted in a new report published by Coherent Market Insights.A) Market Overview:Myelodysplastic Syndrome (MDS) is a group of disorders characterized by abnormal development of blood cells. It is a type...
0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
Спонсоры